SEC Form 4 · accession 0001127602-18-021726
BIOCRYST PHARMACEUTICALS INC · BCRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Fred E Cohen
Director
Period of report
Jun 20, 2018
Accepted (ET)
Jun 22, 2018 · 9:29 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000882796
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Automatic Stock Option GrantF1,F2 | $6.09 | Jun 20, 2018 | A | 30,000 | A | Jul 20, 2018 | Jun 20, 2028 | Common Stock | 30,000 | 30,000 | D |
Explanation of responses
- F1Automatic non-employee director grant pursuant to the BioCryst Pharmaceuticals, Inc. Stock Incentive Plan.
- F2Vests 1/12th per month over twelve months beginning July 20, 2018.